Investment Summary

GIMV Invests In Picot

On June 9, 2022, private equity firm GIMV invested in safety/security company Picot

Investment Highlights
  • This is GIMV’s 2nd transaction in the Safety/Security sector.
  • This is GIMV’s 30th transaction in France.

Investment Summary

Date 2022-06-09
Target Picot
Sector Safety/Security
Investor(s) GIMV
Deal Type Stake Purchase

Target

Picot

Congrier, France
Picot produces fencing and gates, distributes its products through various channels to the private and corporate markets, and is also active in the installation of fencing solutions. Picot was founded in 1921 and is based in Congrier, France.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.


DEAL STATS #
Overall 154 of 170
Sector: Safety/Security M&A 2 of 2
Type: Stake Purchase M&A Deals 10 of 11
Country: France M&A 30 of 32
Year: 2022 M&A 7 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-07 ImmunOs Therapeutics

Schlieren, Switzerland

ImmunOs Therapeutics is a preclinical stage biotech company which develops a proprietary target discovery platform allowing to discover novel molecules inspired by HLA molecules and physiological immunosuppressive molecules. ImmunOs Therapeutics was founded in 2014 and is based in Schlieren, Switzerland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-12 Lenaerts

Houthalen-Helchteren, Belgium

Lenaerts focus on electrical engineering, mainly in industrial installation techniques. Lenaertsis offering a total solution in electricity, heating, plumbing, ventilation and climate control, security systems plus maintenance and service of all such installations. Lenaerts was founded in 1981 and is based in Houthalen-Helchteren, Belgium.

Buy -